Case Report: Response to Savolitinib/EGFR-TKI Combination in NSCLC Patients Harboring Concurrent Primary MET Amplification/overexpression and EGFR Mutation
FRONTIERS IN ONCOLOGY（2024）
关键词
primary MET amplification,MET overexpression,EGFR mutation,Savolitinib,EGFR-TKI,non-small cell lung cancer (NSCLC)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要